DEADLINE: 21ST JULY, 2021
LAGOS STATE GOVERNMENT
IBILE HOLDINGS LIMITED
(THE INVESTMENT COMPANY OF THE LAGOS STATE GOVERNMENT)
KAJOLA HOUSE, 62/64 CAMPBELL STREET, LAGOS
MAIL: INFO@IBILEHOLDINGS.COM
REQUEST FOR PROPOSAL (RFP) FOR THE DEVELOPMENT OF PROPOSED ONCOLOGY CENTRE
7TH JULY, 2021
PREAMBLE:
Cancer is a major global health problem with records of about 10 million incidences, of which a sixth of the cases, result in fatalities. Nigeria, with its challenges of inadequate reporting and record keeping, documents new diagnoses of more than 100,000 and more than 70,000 cancer related deaths annually. It is, therefore, projected that Lagos, which accounts for about 10% of Nigeria’s population may record more than 10,000 new cancer cases and 7,000 cancer-related deaths annually. Meanwhile, due to the ageing of the population, increased environmental degradation, toxic agricultural and food handling processes, public awareness, screening and diagnostic capacities, there may be more registered incidences of cancer, in Nigeria, in the immediate future.
Hence, the desire of the Lagos State Government (LASG) to develop a pilot comprehensive Oncology Centre in the State to address the medical challenge.
LASG has approved for Ibile Holdings Limited (IBILE), the State Government’s Investment Company, to execute a medical services support initiative tagged Medical Diagnostics and Services Provision Scheme (MDSPS), which purpose is to improve healthcare delivery in Lagos State, by utilizing private investment to deliver identified deficient medical services and infrastructure on mutual terms, including joint ventures and structured deferred payments. The proposed Oncology Centre will be on-boarded under MDSPS
INVITATION FOR PROPOSALS
It is in the light of the above that IBILE extends this invitation to interested and competent health service Firms/Companies; specialist Oncology and health entrepreneurs/investors for pre-qualification, consideration, and probable selection as the preferred partner on the proposed Lagos State Oncology Centre. Respondents to this RFP will be required to demonstrate the requisite capacity, skills and expertise in fundraising, design, development, and management of healthcare facilities, but Oncology experience will be an added advantage.
SCOPE OF WORK
LASG’s broad objective is to provide for the prevention, and better management of cancer affictions to the citizens, in the bid to consciously slow down the rate of mortality and increase survivorship, through a partnership, establish a comprehensive Cancer Centre and institutionalize a cancer management system that is tailored to provide end-to-end management of all types of cancers, research and development.
The successful partner should possess the capacity to either alone, or in consortium with other partners, design, develop, equip, train available domestic resources, and operate the proposed Cancer Centre on agreed terms.
The Centre should be adequate in qualitatively providing all of the following services and at affordable costs:
(i) Routine and Specialized Diagnosis.
(ii) Medical Haemato-Oncology.
(iii) Surgical Oncology
(iv) Radiation Oncology
(v) Bone Marrow or Stem Cell Transplant.
The Centre will also drive the State’s holistic vision for prevention and comprehensive cancer care, which spans:
(i) Policy Creation/Revision, Advocacy and Awareness
(ii) Screening and Diagnosis.
(iii) Treatment
(iv) Rehabilitation and Survivorship.
(v) Palliative Care.
(vi) Research and Development
BASELINE REQUIREMENT
The preferred Fim/Company is expected to have the following expertise, qualification, and capabilities:
(i) A practical knowledge and vast experience in medical services-design, financing. construction, project management, healthcare administration, research, and development
(ii) An in depth knowledge and specialist experience in oncology services;
(iii) Evidence of successful execution of similar projects;
(iv) Ability to access requisite funding:
(v) Evidence of mutual partnership with relevant OEMs
(vi) Ability to access and provide long-term support services-training, technology transfer, administration, research & development
ELIGIBILITY REQUIREMENTS
The RFP must be accompanied with the following
(i) Certificate of Incorporation of Company Firm registration in Nigeria and for foreign firm,
evidence of being a legal entity registered with an appropriate entity in its country of origin;
(ii) Evidence of registration and compliance with relevant statutory provisions-VAT, PAYE, Pension, etc.;
(iii) Evidence of current registration with Lagos State Public Procurement Agency (PPA):
(iv) Evidence of current registration of the Firm(s) with recognized Professional bodies;
(v) Evidence of financial capability to execute the project by submission cf Reference Letter from a reputable Commercial Bank in Nigeria or overseas; indicating willingness to provide credit facility for the project, when needed:
(vi) The last 3-Years Audited Financial Statements and latest Management Accounts:( 2018, 2019, 2020)
(vii) Evidence of current Tax Clearance Certificate (TCC) for the last three(3) years and valid till 31st December, 2021.
(viii) Company’s profile with evidence of similar experiences and the curriculum vitae of key staff to be deployed for the project
(ix) All documents for submission under this RFP must be transmitted with a covering letter on the Firm’s/Company’s letterhead and signed by its authorized officer.
SUBMISSION OF DOCUMENT
All Proposals (RFPs) must be written in English language and submitted in four (4) copies-one (1) original copy and three (3) counterpart copies. They should be delivered, not later than 12 noon 21ST JULY, 2021 (i.e., two (2) weeks from the date of this publication), in a sealed envelope dearly marked RFP: “PROPOSED DEVELOPMENT OF ONCOLOGY CENTRE” to the address below
The Managing Director CEO,
Ibile Holdings Limited,
Kajola House, 62/64 Campbell Street, Lagos
It should be noted that this RFP does not constitute a commitment on the part of the State and/or Ibile Holdings Limited to award the project to any Firm/Consortium expressing interest
Furthermore, submission of documents shall not entitle any of the interested parties to any claim against the State and/or lbile Holdings Limited by virtue of such party having responded to the RFP
All costs incurred by respondents as a result of this RFP and any subsequent requests for information shall be for the respondent’s account only
Signed:
Managing Director/CEO
IBILE HOLDINGS LIMITED
(The Investment Company of Lagos State Government)
